tiprankstipranks
Trending News
More News >
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
US Market

Atara Biotherapeutics (ATRA) Ratios

Compare
1,146 Followers

Atara Biotherapeutics Ratios

ATRA's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, ATRA's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.74 0.72 3.74 3.64 6.31
Quick Ratio
3.72 0.65 3.72 3.64 6.31
Cash Ratio
1.18 0.18 1.18 1.00 2.42
Solvency Ratio
-9.08 -1.02 -9.08 -17.98 -24.30
Operating Cash Flow Ratio
-3.43 -1.36 -3.43 -2.08 -2.18
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 45.30M$ -162.87M$ 45.30M$ 196.11M$ 397.49M
Leverage Ratios
Debt-to-Assets Ratio
0.19 0.35 0.19 0.05 0.02
Debt-to-Equity Ratio
0.57 -0.58 0.57 0.09 0.03
Debt-to-Capital Ratio
0.36 -1.40 0.36 0.08 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.97 -1.67 2.97 1.67 1.27
Debt Service Coverage Ratio
-107.62 -50.33 -107.62 0.00 0.00
Interest Coverage Ratio
-141.25 -52.22 -141.25 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
18.06 14.91 18.06 6.81 4.41
Net Debt to EBITDA
0.10 -0.12 0.10 0.24 0.63
Profitability Margins
Gross Profit Margin
77.08%-3.65%77.08%44.05%0.00%
EBIT Margin
-359.10%-3159.06%-359.10%-1673.85%0.00%
EBITDA Margin
-336.18%-3102.73%-336.18%-1627.91%0.00%
Operating Profit Margin
-441.25%-3219.48%-441.25%-1673.85%0.00%
Pretax Profit Margin
-359.10%-3220.70%-359.10%-1672.05%0.00%
Net Profit Margin
-3591.18%-3220.88%-3591.18%-16722.76%0.00%
Continuous Operations Profit Margin
-359.12%-3220.88%-359.12%-1672.28%0.00%
Net Income Per EBT
1000.05%100.01%1000.05%1000.14%1000.05%
EBT Per EBIT
81.38%100.04%81.38%99.89%99.21%
Return on Assets (ROA)
-606.51%-166.84%-606.51%-726.60%-521.36%
Return on Equity (ROE)
-1802.76%278.27%-1802.76%-1216.47%-663.19%
Return on Capital Employed (ROCE)
-94.29%-1185.69%-94.29%-93.96%-61.17%
Return on Invested Capital (ROIC)
-90.16%-778.47%-90.16%-93.27%-60.94%
Return on Tangible Assets
-606.51%-166.84%-606.51%-726.60%-521.36%
Earnings Yield
-682.46%-508.41%-682.46%-230.41%-211.16%
Efficiency Ratios
Receivables Turnover
1.58 0.25 1.58 20.63 0.00
Payables Turnover
2.12 2.41 2.12 0.66 1.39
Inventory Turnover
9.19 0.92 9.19 11.38M 0.00
Fixed Asset Turnover
0.86 0.15 0.86 0.25 0.00
Asset Turnover
0.17 0.05 0.17 0.04 0.00
Working Capital Turnover Ratio
0.26 0.10 0.26 0.06 0.00
Cash Conversion Cycle
98.51 1.70K 98.51 -539.36 -263.31
Days of Sales Outstanding
230.93 1.45K 230.93 17.69 0.00
Days of Inventory Outstanding
39.74 398.68 39.74 <0.01 0.00
Days of Payables Outstanding
172.15 151.32 172.15 557.06 263.31
Operating Cycle
270.66 1.85K 270.66 17.69 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-66.29 -45.55 -66.29 -58.86 -61.09
Free Cash Flow Per Share
-67.32 -45.84 -67.32 -61.68 -62.61
CapEx Per Share
1.03 0.29 1.03 2.82 1.53
Free Cash Flow to Operating Cash Flow
1.02 1.01 1.02 1.05 1.02
Dividend Paid and CapEx Coverage Ratio
-64.50 -157.79 -64.50 -20.84 -40.05
Capital Expenditure Coverage Ratio
-64.50 -157.79 -64.50 -20.84 -40.05
Operating Cash Flow Coverage Ratio
-3.77 -3.33 -3.77 -8.64 -13.86
Operating Cash Flow to Sales Ratio
-4.25 -22.51 -4.25 -10.84 0.00
Free Cash Flow Yield
-82.09%-357.57%-82.09%-15.65%-12.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.15 -0.20 -0.15 -0.43 -0.47
Price-to-Sales (P/S) Ratio
5.26 6.34 5.26 72.58 0.00
Price-to-Book (P/B) Ratio
2.64 -0.55 2.64 5.28 3.14
Price-to-Free Cash Flow (P/FCF) Ratio
-1.22 -0.28 -1.22 -6.39 -7.84
Price-to-Operating Cash Flow Ratio
-1.24 -0.28 -1.24 -6.69 -8.03
Price-to-Earnings Growth (PEG) Ratio
<0.01 -0.01 <0.01 0.04 0.02
Price-to-Fair Value
2.64 -0.55 2.64 5.28 3.14
Enterprise Value Multiple
-1.47 -0.32 -1.47 -4.22 -4.26
Enterprise Value
313.29M 86.34M 313.29M 1.40B 1.26B
EV to EBITDA
-1.47 -0.32 -1.47 -4.22 -4.26
EV to Sales
4.93 10.07 4.93 68.62 0.00
EV to Free Cash Flow
-1.14 -0.44 -1.14 -6.04 -6.83
EV to Operating Cash Flow
-1.16 -0.45 -1.16 -6.33 -7.00
Tangible Book Value Per Share
31.04 -23.42 31.04 74.63 156.25
Shareholders’ Equity Per Share
31.04 -23.42 31.04 74.63 156.25
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
15.58 2.02 15.58 5.43 0.00
Net Income Per Share
-559.62 -65.18 -559.62 -907.82 -1.04K
Tax Burden
10.00 1.00 10.00 10.00 10.00
Interest Burden
1.00 1.02 1.00 1.00 1.00
Research & Development to Revenue
4.29 26.22 4.29 13.86 0.00
SG&A to Revenue
1.13 5.94 1.13 3.87 0.00
Stock-Based Compensation to Revenue
0.85 5.29 0.85 2.65 0.00
Income Quality
1.18 0.70 1.18 0.65 0.59
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis